// App-Quantinova.ai

THU0215 (2018) : Efficacy of sarilumab in patients with rheumatoid arthritis with and without previous response to tocilizumab

Researchers

Presenter

  • P. Verschueren

Principal Investigators

  • P. Emery

  • H. van Hoogstraten

  • Q. Dong

  • E.K. Mangan

  • A. den Broeder

Medical Centers

  • Division of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium

  • Sanofi Genzyme, Bridgewater, NJ

  • Regeneron Pharmaceuticals, Inc., Tarrytown, NY

  • Hengstdal , Sint Maartenskliniek, Nijmegen, Netherlands

Locations

  • Belgium

  • United Kingdom

  • United States

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • C reactive protein

  • Albumin/creatinine

Drug/Treatment

  • Tocilizumab

  • Sarilumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01768572

  • NCT01146652

Sponsors

  • Sanofi and Regeneron Pharmaceuticals

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved